What it sells
Medical language models to automate healthcare operations
Business model breakdown
Buyer: who owns the budget?
UnverifiedPharmacy and health-system leaders (e.g. pharmacy directors at systems like Mount Sinai, Ochsner).
Trigger: what makes them buy now?
Growing specialty-drug volume without added staff; prior-authorization workload, denials and lost specialty fills.
Workflow: what inputs become what output?
Clinical agent engine identifies patients, handles eligibility and prior authorization and appeals, routes benefits, and supports patients with check-ins.
Economics: what it saves and how it charges
Enterprise platform contract; claims USD 300K annual labor cost avoided, 2x more prior auths per team member, appeals drafted in 7 min vs 30, USD 50M copay assistance secured.
Distribution: how it reaches customers
Enterprise sales (contact us, case studies); 60+ US health systems.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2023 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.